Trial Profile
Experiences with Montelukast orally disintegrating tablets in patients with asthma and/or allergic rhinitis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Sep 2017
Price :
$35
*
At a glance
- Drugs Montelukast (Primary)
- Indications Allergic rhinitis; Asthma
- Focus Therapeutic Use
- 22 Sep 2017 New trial record